In one of the largest studies of early cardiogenic shock (CS) patients, where blood flow is still functioning to vital organs ...

The first study evaluating Medicare patients undergoing percutaneous coronary intervention (PCI) in ambulatory surgery ...

The SOUL trial showed that oral semaglutide was safe in patients with type 2 diabetes and atherosclerotic cardiovascular ...

Amgen today announced financial results for the first quarter of 2025. "Demand for our products was strong globally in the first quarter. Ongoing new product launches and successful Phase 3 trial ...

With mepolizumab vs. placebo, patients with COPD and type 2 inflammation experienced significantly fewer moderate/severe ...

No-touch’ vein harvesting significantly reduces the risk of graft failure up to three years after coronary artery bypass ...

No-touch’ vein harvesting significantly reduces the risk of graft failure up to three years after coronary artery bypass ...

Separating stereoisomers is an extensively researched and challenging process, with approved substances being rare. A new SFC ...

Avacopan has been shown to work well in a real-world setting in a much broader group of people with vasculitis than was studied in the phase 3 trial that led to its approval.

NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has received FDA approval to move forward with its Virtue Trial ...

The Hummingbird Diagnostics Product Pipeline Analysis highlights the company's miRNA-based liquid biopsy innovations for early detection of cancer, ...